MustGrow Biologics Corp. (FRA:0C0)

Market Cap	23.03M -57.8%
Revenue (ttm)	4.61M +51.0%
Net Income	-3.90M
EPS	-0.07
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6,448
Open	0.3600
Previous Close	0.3460
Day's Range	0.3600 - 0.3600
52-Week Range	0.3040 - 0.8900
Beta	n/a
RSI	45.14
Earnings Date	Apr 23, 2026

About MustGrow Biologics

MustGrow Biologics Corp., an agricultural biotechnology company, focuses on development and commercialization of natural biological technologies and products from mustard plants. The company provides Biocontrol technology platform to treat soil-borne diseases and pests for various crops, including fruit, vegetables, and others; treat unwanted plant growth for use in organic agriculture, and home and garden markets, as well as agriculture markets where glyphosate has been banned; and suppress sprouting, and treat disease and pathogen for storage...

• Industry: Agricultural Chemicals
• Founded: 2014
• Country: Canada
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0C0

Financial Performance

In 2024, MustGrow Biologics's revenue was 398,018, a decrease of -91.55% compared to the previous year's 4.71 million. Losses were -4.89 million, 622.2% more than in 2023.

Financial numbers in CAD